WallStSmart

Tucows Inc. (TCX)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tucows Inc. generates 51% more annual revenue ($390.30M vs $258.90M). ZEPP leads profitability with a -15.5% profit margin vs -19.4%. TCX earns a higher WallStSmart Score of 48/100 (D+).

TCX

Hold

48

out of 100

Grade: D+

Growth: 7.3Profit: 2.0Value: 6.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

TCXUndervalued (+64.7%)

Margin of Safety

+64.7%

Fair Value

$50.27

Current Price

$15.73

$34.54 discount

UndervaluedFair: $50.27Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

TCX1 strengths · Avg: 10.0/10
EPS GrowthGrowth
90.2%10/10

Earnings expanding 90.2% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

TCX4 concerns · Avg: 2.8/10
PEG RatioValuation
1.894/10

Expensive relative to growth rate

Market CapQuality
$181.93M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-1012.0%2/10

ROE of -1012.0% — below average capital efficiency

Free Cash FlowQuality
$-6.96M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : TCX

The strongest argument for TCX centers on EPS Growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : TCX

The primary concerns for TCX are PEG Ratio, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

TCX profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TCX scores higher overall (48/100 vs 41/100). ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Tucows Inc.

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Tucows Inc. provides network access, domain name registration, email, mobile phone, and other Internet services in Canada, the United States, and Europe. The company is headquartered in Toronto, Canada.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?